"The VA Greater Los Angeles Healthcare System (VAGLAHS) is one component of the VA Desert Pacific Healthcare Network (VISN22) offering services to Veterans residing in Southern California. VAGLAHS consists of two ambulatory care centers, a tertiary care facility and 9 community-based outpatient clinics. VAGLAHS serves Veterans residing throughout five counties: Kern, Los Angeles, San Luis Obispo, Santa Barbara, and Ventura. There are approximately 1.4 million Veterans in the VAGLAHS service area. For more information, call (310) 268-3340 or visit us at. Veterans in need can call the VA hotline toll-free at 877-4-AID-VET."

During the past decade, VA Greater Los Angeles Healthcare System, West Los Angeles, CA conducted 103 clinical trials. In the 10-year time frame, 103 clinical trials started and 83 clinical trials were completed, i.e. on average, 80.6% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 40 clinical trials were completed. i.e. 90.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "VA Greater Los Angeles Healthcare System, West Los Angeles, CA" #1 sponsor was "VA Office of Research and Development" with 72 trials, followed by "US Department of Veterans Affairs" with 46 trials sponsored, "VA Greater Los Angeles Healthcare System" with 14 trials sponsored, "Gilead Sciences" with 9 trials sponsored and "United Therapeutics" with 9 trials sponsored. Other sponsors include 83 different institutions and companies that sponsored additional 66 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "VA Greater Los Angeles Healthcare System, West Los Angeles, CA" #1 collaborator was "VA Greater Los Angeles Healthcare System" with 14 trials as a collaborator, "University of California, Los Angeles" with 12 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 6 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials as a collaborator. Other collaborators include 144 different institutions and companies that were collaborators in the rest 130 trials.

According to Clinical.Site data, the most researched conditions in "VA Greater Los Angeles Healthcare System, West Los Angeles, CA" are "Schizophrenia" (18 trials), "Pulmonary Arterial Hypertension" (13 trials), "Obesity" (11 trials), "Prostate Cancer" (10 trials) and "Pulmonary Hypertension" (9 trials). Many other conditions were trialed in "VA Greater Los Angeles Healthcare System, West Los Angeles, CA" in a lesser frequency.

Most popular intervention types in "VA Greater Los Angeles Healthcare System, West Los Angeles, CA" are "Drug" (111 trials), "Behavioral" (50 trials), "Other" (37 trials), "Device" (25 trials) and "Procedure" (21 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "placebo" (6 trials), "Emotional Awareness and Expression Therapy" (3 trials), "Ribavirin" (3 trials) and "177Lu-PSMA-617" (2 trials). Other intervention names were less common.

The vast majority of trials in "VA Greater Los Angeles Healthcare System, West Los Angeles, CA" are 204 trials for "All" genders, 29 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are 62 active trials in "VA Greater Los Angeles Healthcare System, West Los Angeles, CA". 3 are not yet recruiting, 34 are recruiting, 20 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 136 completed trials in VA Greater Los Angeles Healthcare System, West Los Angeles, CA, undefined suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in VA Greater Los Angeles Healthcare System, West Los Angeles, CA, 13 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 17 trials, and there were also 87 trials that are defined as “Not Applicable".